With hundreds of drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions and mitigate financial losses. These include ...

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

Neuralink has successfully completed two brain implant surgeries in a single day. Sharing the achievement, Elon Musk ...

Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

Sarepta Therapeutics faces an "arduous path” to try to get its gene therapy for Duchenne muscular dystrophy back onto the market, a senior FDA official told STAT.

Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

When it comes to birth control, the market has long been skewed: female contraception comes in a variety of pills, implants, ...

An experimental birth control pill for males works by blocking sperm production, and it just passed its first safety test in humans.

Albertsons Companies stores in the U.S. states of Arkansas, Louisiana, Oklahoma, and Texas have all also voluntarily recalled ...